We are live on ! Find out more
OBCI

Ocean Bio-Chem Inc

Delisted

OBCI was delisted on the 8th of August, 2022.

17 hedge funds and large institutions have $1.32M invested in Ocean Bio-Chem Inc in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

2% more capital invested

Capital invested by funds: $1.3M → $1.32M (+$21K)

0% more funds holding

Funds holding: 1717 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OBCI Hedge Fund Activity: Q4 2019 in Review

17 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem Inc (OBCI) for Q4 2019, worth a combined $1.32M — up 1.6% from $1.3M a quarter earlier.

Fund positioning in OBCI was balanced in Q4 2019: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Essex Investment Management, adding an estimated $18.1K. The largest seller was Victory Capital Management, exiting entirely with an estimated $3K sold.

  • 17 institutional investors held Ocean Bio-Chem Inc (OBCI) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $1.32M of Ocean Bio-Chem Inc stock for Q4 2019, up 1.6% quarter-over-quarter.
  • 2 funds opened new Ocean Bio-Chem Inc positions in Q4 2019 and 2 closed out, a net change of 0 holders.
  • The largest Ocean Bio-Chem Inc buyer in Q4 2019 was Essex Investment Management, an estimated $18.1K added.
  • The largest Ocean Bio-Chem Inc seller in Q4 2019 was Victory Capital Management, an estimated $3K sold.

Based on aggregated 13F filings for Q4 2019.